Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Glaucoma: Overview01:25

Glaucoma: Overview

1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

267
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
267

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainable Pd-Catalyzed Aminations "on Dirty Water".

Angewandte Chemie (International ed. in English)·2026
Same author

Impact of a Patient Navigator Program on Access to Outpatient Ophthalmic Surgery.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

American journal of ophthalmology·2026
Same author

Carbon mesopore depth engineering boosts the performance of low-platinum fuel cells.

Nature communications·2026
Same author

Medium-Sized Intermetallic PtCo Catalysts for Low-Pt Heavy-Duty Fuel Cells.

Angewandte Chemie (International ed. in English)·2026
Same author

Leveraging Natural Language Processing to Assess Follow-Up Patterns in Glaucoma Care.

Ophthalmology. Glaucoma·2026

Related Experiment Video

Updated: Feb 26, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.2K

Characteristics Associated with Appointment No-Show at an Academic Uveitis Service.

Christina L Kong1, Lola Ortiz-Whittingham1, Hai-Wei Liang1

  • 1Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Ocular Immunology and Inflammation
|February 24, 2026
PubMed
Summary

Younger age, Black race, Medicaid insurance, and blindness are linked to higher no-show rates in uveitis patients. Interventions targeting these factors can reduce missed appointments and improve eye disease treatment.

Keywords:
Appointment nonattendancehealth disparitieslapses in careloss to follow-upno-show

More Related Videos

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K

Related Experiment Videos

Last Updated: Feb 26, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.2K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K

Area of Science:

  • Ophthalmology
  • Health Services Research

Background:

  • Uveitis is a group of inflammatory eye conditions requiring consistent monitoring.
  • Appointment no-shows (NS) can lead to delayed treatment and potentially worse outcomes for chronic conditions like uveitis.

Purpose of the Study:

  • To identify patient characteristics associated with appointment no-shows in a tertiary academic uveitis service.
  • To inform targeted interventions for reducing no-show rates among uveitis patients.

Main Methods:

  • Retrospective cohort study analyzing electronic health records from 2019-2023.
  • Identified no-shows as appointments not attended or cancelled within 24 hours.
  • Used univariable and multivariable regression models to determine risk factors for no-shows.

Main Results:

  • 36.4% of 1,081 uveitis patients had at least one no-show visit.
  • Younger age (<60 years), Black race, Medicaid insurance, and blindness were significant risk factors for no-shows.
  • Sensitivity analyses confirmed the robustness of these findings.

Conclusions:

  • Patient demographics and clinical factors like age, race, insurance, and blindness significantly impact uveitis appointment no-show rates.
  • Addressing these disparities through targeted interventions is crucial for mitigating no-shows and preventing undertreatment of sight-threatening uveitis.